摘要
目的:探讨inv(16)和CBFβ-MYH11融合基因在急性髓系白血病M4EO型的临床诊断、预后判断中的意义。方法:用逆转录-聚合酶链反应(RT-PCR)和荧光原位杂交(FISH)技术分别检测急性粒-单核细胞白血病(M4)患者的CBFβ-MYH11融合基因转录本和inv(16)。结果:在15例中国人M4中,10例患者用RT-PCR方法检测CBFβ-MYH11融合基因转录本,其中9例不伴异常嗜酸粒细胞的M4中有1例阳性;1例伴异常嗜酸粒细胞增多(M4EO)为阳性。随访该例完全缓解2个月后,其PCR仍持续阳性。用FISH技术检测的9例M4中得到的2例阳性病例,与PCR方法测得的结果完全一致。结论:对M4患者无论其经典的染色体核型分析有无16号染色体异常的提示,都应用RT-PCR和FISH方法检测CBFβ-MYH11融合基因进行筛选,这对M4的临床诊断、预后判断等具有重要临床价值。
Objective:To study the clinical significance of inv(16) and CBFβMYH11 fusion gene in the diagnosis and prognosis for M4Eo.Methods:CBFβMYH11 fusion transcripts and inv (16) were analyzed by reversetranscriptase polymerase chain reaction(RTPCR) and fluorescence in situ hybridization(FISH),respectively,in acute myelomonocytic leukemia(M4) with or without eosinophilia.Results:In fifteen cases tested,one case of M4Eo and one of 9 M4 without eosinophilia were found to have CBFβMYH11 fusion transcript.Followup of the M4Eo patient showed residual PCR positivity 2 months after complete remission.Conclusion:The data suggest that screening by both RTPCR and FISH should be performed in all AMLM4 regardless of morphologic features to allow accurate diagnosis and prognosis of M4 patients.
出处
《中华血液学杂志》
CAS
CSCD
北大核心
1998年第1期23-26,共4页
Chinese Journal of Hematology
关键词
白血病
AML
融合基因
CBFβ-MYH11
聚合酶链反应
Leukemia
myelomonocytic
acute
Fusion gene
CBFβMYH11
Polymerase chain reaction
Fluorescence in situ hybridization